Compare Barrick Gold Corp (B) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Barrick Gold Corp vs Summit Therapeutics Inc — how do they compare? Barrick Gold Corp trades at $41.11 (market cap $65.92B), while Summit Therapeutics Inc trades at $15.5 (market cap $12.06B). The key difference: Barrick Gold Corp is far larger — about 5.5× Summit Therapeutics Inc's market cap, and Barrick Gold Corp pays a 1.74% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| B | SMMT | |
|---|---|---|
Market Cap | $65.92B | $12.06B |
Sector | Basic Materials | Health |
52-Week High | $52.97 | $26.98 |
52-Week Low | $23.50 | $12.55 |
Enterprise Value | $64.67B | $11.39B |
Dividend Yield | 1.74% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Barrick Mining (B) trades at $40.91, down 6.36% today, but maintains strong fundamentals with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $40 and resistance at $42, while recent developments include a $1.95 billion settlement with Newmont and plans for a North American gold IPO. Revenue growth accelerated to $17.0 billion in 2025 with net income reaching $5.0 billion, supported by a 31.6% net margin.
The outlook remains positive with 66.7% analyst buy ratings and a $49.83 consensus price target representing 22% upside. Key risks include gold price volatility and execution of the planned IPO, but strong cash flow generation and debt reduction provide stability for continued shareholder returns through dividends and potential buybacks.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Barrick Gold Corp
Barrick Gold Corp is one of the world's largest gold producers, operating mines in North America, South America, Australia, and Africa. The company segments consist of nine gold mines namely Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, and Bulyanhulu. It generates maximum revenue from the Carlin mine segment. Geographically, it derives a majority of revenue from the United States.
Read more on B →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
